glycine has been researched along with Venous Thromboembolism in 2 studies
Venous Thromboembolism: Obstruction of a vein or VEINS (embolism) by a blood clot (THROMBUS) in the blood stream.
Excerpt | Relevance | Reference |
---|---|---|
"Rivaroxaban has a flat dose-dependent anticoagulant response with a wide therapeutic window and low potential for drug-drug and drug-food interactions." | 1.35 | Factor Xa inhibitors--new anticoagulants for secondary haemostasis. ( Perzborn, E, 2009) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Perzborn, E | 1 |
Harenberg, J | 1 |
Wehling, M | 1 |
1 review available for glycine and Venous Thromboembolism
Article | Year |
---|---|
Current and future prospects for anticoagulant therapy: inhibitors of factor Xa and factor IIa.
Topics: Acute Coronary Syndrome; Administration, Oral; Anticoagulants; Atrial Fibrillation; Azetidines; Benz | 2008 |
1 other study available for glycine and Venous Thromboembolism
Article | Year |
---|---|
Factor Xa inhibitors--new anticoagulants for secondary haemostasis.
Topics: Administration, Oral; Anticoagulants; Factor Xa Inhibitors; Glycine; Hemostasis; Humans; Morpholines | 2009 |